Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): a cluster randomised controlled trial protocol

Christina Abdel Shaheed*, Rowena Ivers, Lisa Vizza, Andrew McLachlan, Patrick J. Kelly, Fiona Blyth, Fiona Stanaway, Philip James Clare, Rachel Thompson, Thomas Lung, Louisa Degenhardt, Sharon Reid, Bradley Martin, Michael Wright, Rawa Osman, Simon French, Kirsten McCaffery, Gabrielle Campbell, Hazel Jenkins, Stephanie MathiesonMonika Boogs, Jarrod McMaugh, Carol Bennett, Christopher Maher

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

80 Downloads (Pure)

Abstract

Introduction: Low back pain (LBP) is commonly treated with opioid analgesics despite evidence that these medicines provide minimal or no benefit for LBP and have an established profile of harms. International guidelines discourage or urge caution with the use of opioids for back pain; however, doctors and patients lack practical strategies to help them implement the guidelines. This trial will evaluate a multifaceted intervention to support general practitioners (GPs) and their patients with LBP implement the recommendations in the latest opioid prescribing guidelines.

Methods and analysis: This is a cluster randomised controlled trial that will evaluate the effect of educational outreach visits to GPs promoting opioid stewardship alongside non-pharmacological interventions including heat wrap and patient education about the possible harms and benefits of opioids, on GP prescribing of opioids medicines dispensed. At least 40 general practices will be randomised in a 1:1 ratio to either the intervention or control (no outreach visits; GP provides usual care). A total of 410 patient-participants (205 in each arm) who have been prescribed an opioid for LBP will be enrolled via participating general practices. Follow-up of patient-participants will occur over a 1-year period. The primary outcome will be the cumulative dose of opioid dispensed that was prescribed by study GPs over 1 year from the enrolment visit (in morphine milligram equivalent dose). Secondary outcomes include prescription of opioid medicines, benzodiazepines, gabapentinoids, non-steroidal anti-inflammatory drugs by study GPs or any GP, health services utilisation and patient-reported outcomes such as pain, quality of life and adverse events. Analysis will be by intention to treat, with a health economics analysis also planned.

Ethics and dissemination: The trial received ethics approval from The University of Sydney Human Research Ethics Committee (2022/511). The results will be disseminated via publications in journals, media and conference presentations.

TRIAL REGISTRATION NUMBER: ACTRN12622001505796.

Original languageEnglish
Article numbere075286
Pages (from-to)1-10
Number of pages10
JournalBMJ Open
Volume13
Issue number11
DOIs
Publication statusPublished - Nov 2023

Bibliographical note

Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Humans
  • Analgesics, Opioid/therapeutic use
  • Low Back Pain/drug therapy
  • Quality of Life
  • Practice Patterns, Physicians'
  • General Practitioners
  • Randomized Controlled Trials as Topic
  • Back pain
  • Protocols & guidelines
  • Primary Health Care

Fingerprint

Dive into the research topics of 'Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): a cluster randomised controlled trial protocol'. Together they form a unique fingerprint.

Cite this